ArticleThe European respiratory journal2025

Tofacitinib in anti-MDA5-positive dermatomyositis-associated interstitial lung disease: a new standard of care emerges.

Toyoshi Yanagihara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.